Quest Diagnostics INC Form 4 insider transactions

Patrick Plewman, SVP of Diagnostic Services at Quest Diagnostics, sold shares to cover tax obligations arising from the vesting of restricted share units.

Catherine T. Doherty, an executive at Quest Diagnostics, sold shares of company stock to cover tax obligations arising from vesting restricted share units and also executed sales under a pre-arranged 10b5-1 plan.

Michael E. Prevoznik, SVP & General Counsel of Quest Diagnostics, reports the sale of common stock to cover tax obligations and a sale pursuant to a Rule 10b5-1 plan.

Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, reported disposing of common stock to cover tax obligations arising from vesting restricted share units.

Executive Vice President & CFO of Quest Diagnostics, Sam Samad, reports the sale of 656 shares of common stock to cover tax obligations arising from vesting of restricted share units.

CEO James E. Davis of Quest Diagnostics reports disposing of common stock to cover tax obligations arising from vested restricted share units.

Mark A. Gardner, SVP of Molecular Gen & Oncol at Quest Diagnostics, sold 262 shares of common stock on February 28, 2024, to cover tax obligations arising from vesting restricted share units.

Michael J. Deppe, SVP, Corp. Controller & CAO of Quest Diagnostics, sold shares to cover tax obligations arising from vesting of restricted share units.

Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, sold 225 shares of common stock on February 28, 2024, to cover tax obligations arising from vesting restricted share units.

CEO James E. Davis reports acquisition and disposition of Quest Diagnostics (DGX) common stock related to a performance share award.

Michael E. Prevoznik, SVP & General Counsel of Quest Diagnostics, reports acquisition and disposition of common stock related to a performance share award.

Patrick Plewman, SVP at Quest Diagnostics, reports acquisition and disposition of company stock related to a performance share award.

Catherine T. Doherty, EVP at Quest Diagnostics, reports acquisition and disposition of company stock related to a performance share award.

Karthik Kuppusamy, SVP at Quest Diagnostics, reports acquisition and disposition of company stock related to a performance share award.

Michael J. Deppe, SVP, Corp. Controller & CAO of Quest Diagnostics, reports acquisition and disposition of common stock related to a performance share award settlement.